Lycopene supplementation modulates plasma concentrations and epididymal adipose tissue mRNA of leptin, resistin and IL-6 in diet-induced obese rats

British Journal of Nutrition

Volumn 110, Issue 10, 2013, Pages 1803-1809

  Luvizotto, Renata De Azevedo Melo ^a,b   Nascimento, Andre F ^a,b   Imaizumi, Erika ^a   Pierine, Damiana T ^a,b   Conde, Sandro J ^a   Correa, Camila R ^a   Yeum, Kyung Jin ^b,c   Ferreira, Ana Lucia A ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b TUFTS UNIVERSITY   (United States)

^c Konkuk University   (South Korea)

Author keywords

Adipokines; Lycopene; Obesity

Indexed keywords

INTERLEUKIN 6; LEPTIN; LYCOPENE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DOWN REGULATION; EPIDIDYMIS FAT; GENE EXPRESSION; INSULIN SENSITIVITY; MALE; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; RAT; WISTAR RAT;

ADIPOSE TISSUE; ANIMALS; ANTI-INFLAMMATORY AGENTS; CAROTENOIDS; DIETARY SUPPLEMENTS; ENERGY INTAKE; EPIDIDYMIS; INFLAMMATION; INTERLEUKIN-6; LEPTIN; MALE; OBESITY; PHYTOTHERAPY; PLANT EXTRACTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; RESISTIN; RNA, MESSENGER;

EID: 84887216118     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513001256     Document Type: Article

References (67)

1. Monteiro R & Azevedo I (2010) Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm 2010, 1-10.
2. Astrup A, Buemann B, Western P, et al. (1994) Obesity as an adaptation to a high-fat diet: evidence from a cross-sectional study. Am J Clin Nutr 59, 350-355.
3. World Health Organization (2011) Obesity and Overweight. Geneva: WHO.
4. Henry SL, Bensley JG, Wood-Bradley RJ, et al. (2012) White adipocytes: more than just fat depots. Int J Biochem Cell Biol 44, 435-440.
5. Zhang H & Zhang C (2010) Adipose "talks" to distant organs to regulate insulin sensitivity and vascular function. Obesity (Silver Spring) 18, 2071-2076.
6. Tilg H, Trehu E, Atkins MB, et al. (1994) Interleukin 6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83, 113-118. (Pubitemid 24016522)
7. Eklund CM (2009) Proinflammatory cytokines in CRP baseline regulation. Adv Clin Chem 48, 111-136.
8. Arner P (2003) The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab 14, 137-145. (Pubitemid 36733912)
9. Khera TK, Dick AD & Nicholson LB (2010) Mechanisms of TNFa regulation in uveitis: focus on RNA-binding proteins. Prog Retin Eye Res 29, 610-621.
10. Illán-Gómez F, González-Ortega M, Orea-Soler I, et al. (2012) Obesity and inflammation: change in adiponectin, C reactive protein, tumor necrosis factor-alpha and interleukin-6 after bariatric surgery. Obes Surg 22, 950-955.
11. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115, 911-919.
12. Rasouli N & Kern PA (2008) Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93, S64-S73.
13. Tarkowski A, Bjersing J, Shestakov A, et al. (2010) Resistin competes with lipopolysaccharide for binding to Toll-like receptor 4. J Cell Mol Med 14, 1419-1431.
14. Bokarewa M, Nagaev I, Dahlberg L, et al. (2005) Resistin, an adipokine with potent proinflammatory properties. J Immunol 174, 5789-5795. (Pubitemid 40593223)
15. Pagano C, Soardo G, Pilon C, et al. (2006) Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J Clin Endocrinol Metab 91, 1081-1086. (Pubitemid 43357784)
16. Singhal NS, Patel RT, Qi Y, et al. (2008) Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice. Am J Physiol Endocrinol Metab 295, E331-E338.
17. Indulekha K, Anjana RM, Surendar J, et al. (2011) Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113). Clin Biochem 44, 281-287.
18. Stirnadel H, Lin X, Ling H, et al. (2008) Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study. Atherosclerosis 197, 868-876. (Pubitemid 351417886)
19. Hauner H (2005) Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc 64, 163-169. (Pubitemid 40813538)
20. Khachik F, Carvalho L, Bernstein PS, et al. (2002) Chemistry, distribution, and metabolism of tomato carotenoids and their impact on human health. Exp Biol Med (Maywood) 227, 845-851. (Pubitemid 35340337)
21. Mangels AR, Holden JM, Beecher GR, et al. (1993) Carotenoid content of fruits and vegetables: an evaluation of analytic data. J Am Diet Assoc 93, 284-296. (Pubitemid 23070877)
22. Di Mascio P, Kaiser S & Sies H (1989) Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274, 532-538. (Pubitemid 19261144)
23. Wang S, Konorev EA, Kotamraju S, et al. (2004) Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. Intermediacy of H2O2-and p53-dependent pathways. J Biol Chem 279, 25535-25543. (Pubitemid 38756813)
24. Ferreira ALA, Russell RM, Rocha NS, et al. (2007) Effect of lycopene on doxorubicin-induced cardiotoxicity: an echocardiographic, histological, and morphometrical assessment. Basic Clin Pharmacol Toxicol 101, 16-24. (Pubitemid 46934646)
25. Marcotorchino J, Romier B, Gouranton E, et al. (2012) Lycopene attenuates LPS-induced TNF-a secretion in macrophages and inflammatory markers in adipocytes exposed to macrophage-conditioned media. Mol Nutr Food Res 56, 725-732.
26. Bignotto L, Rocha J, Sepodes B, et al. (2009) Antiinflammatory effect of lycopene on carrageenan-induced paw oedema and hepatic ischaemia-reperfusion in the rat. Br J Nutr 102, 126-133.
27. Hung CF, Huang TF, Chen BH, et al. (2008) Lycopene inhibits TNF-alpha-induced endothelial ICAM-1 expression and monocyte endothelial adhesion. Eur J Pharmacol 586, 275-282.
28. Gouranton E, Thabuis C, Riollet C, et al. (2011) Lycopene inhibits proinflammatory cytokine and chemokine expression in adipose tissue. J Nutr Biochem 22, 642-648.
29. Ghavipour M, Saedisomeolia A, Djalali M, et al. (2013) Tomato juice consumption reduces systemic inflammation in overweight and obese females. Br J Nutr 109, 2031-2035.
30. Nascimento AF, Sugizaki MM, Leopoldo AS, et al. (2008) A hypercaloric pellet-diet cycle induces obesity and comorbidities in Wistar rats. Arq Bras Endocrinol Metab 52, 968-974.
31. Ibrahim HS, Ahmed LA & El-din MME (2008) The functional role of some tomato products on lipid profile and liver function in adult rats. J Med Food 11, 551-559.
32. Ali MM & Agha FG (2009) Amelioration of spreptozotocin induced diabetes mellitus oxidative stress and dyslipidemia in rats by tomato extract lycopene. Scand J Clin Lab Invest 69, 371-379.
33. Bahcecioglu IH, Kuzu N, Metin K, et al. (2010) Lycopene prevents development of steatohepatitis in experimental nonalcoholic steatohepatitis model induced by high-fat diet. Vet Med Int 2010, 1-8.
34. Wang Y, Ausman LM, Greenberg AS, et al. (2010) Dietary lycopene and tomato extract supplementations inhibit nonalcoholic steatohepatitis-promoted hepatocarcinogenesis in rats. Int J Cancer 126, 1788-1796.
35. Gea-Sorl?́ S, Bonjoch L & Closa D (2012) Differences in the inflammatory response induced by acute pancreatitis in different white adipose tissue sites in the rat. PLOS ONE 7, e41933.
36. Yeum KJ, Booth SL, Sadowski JA, et al. (1996) Human plasma carotenoid response to the ingestion of controlled diets high in fruits and vegetables. Am J Clin Nutr 64, 594-602. (Pubitemid 26334239)
37. Nascimento AF, Luvizotto RA, Leopoldo AS, et al. (2011) Long-term high-fat diet-induced obesity decreases the cardiac leptin receptor without apparent lipotoxicity. Life Sci 88, 1031-1038.
38. Coatmellec-Taglioni G, Dausse JP, Ribière C, et al. (2000) Hypertension in cafeteria-fed rats: alterations in renal alpha2-adrenoceptor subtypes. Am J Hypertens 13, 529-534. (Pubitemid 30330716)
39. Livak KJ & Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408. (Pubitemid 34164012)
40. Jang AS, Kim TH, Park JS, et al. (2009) Association of serum leptin and adiponectin with obesity in asthmatics. J Asthma 46, 59-63.
41. van Dijk SJ, Feskens EJ, Bos MB, et al. (2009) A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome. Am J Clin Nutr 90, 1656-1664.
42. Boileau TW, Boileau AC & Erdman JW (2002) Bioavailability of all-trans and cis-isomers of lycopene. Exp Biol Med (Maywood) 227, 914-919. (Pubitemid 35340347)
43. Mathews-Roth MM, Welankiwar S, Sehgal PK, et al. (1990) Distribution of [14C] canthaxanthin and [14C] lycopene in rats and monkeys. J Nutr 120, 1205-1213. (Pubitemid 20359975)
44. Hariri N & Thibault L (2010) High-fat diet-induced obesity in animal models. Nutr Res Rev 23, 270-299.
45. Ainslie DA, Proietto J, Fam BC, et al. (2000) Short-term, high-fat diets lower circulating leptin concentrations in rats. Am J Clin Nutr 71, 438-442. (Pubitemid 30061220)
46. Roberts CK, Barnard RJ, Liang KH, et al. (2002) Effect of diet on adipose tissue and skeletal muscle VLDL receptor and LPL: implications for obesity and hyperlipidemia. Atherosclerosis 161, 133-141. (Pubitemid 34214829)
47. Nascimento AF, Sugizaki MM, Leopoldo AS, et al. (2008) Misclassification probability as obese or lean in hypercaloric and normocaloric diet. Biol Res 41, 253-259.
48. Tentolouris N, Pavlatos S, Kokkinos A, et al. (2008) Diet-induced thermogenesis and substrate oxidation are not different between lean and obese women after two different isocaloric meals, one rich in protein and one rich in fat. Metabolism 57, 313-320. (Pubitemid 351178719)
49. Schrauwen P & Westerterp KR (2000) The role of high-fat diets and physical activity in the regulation of body weight. Br J Nutr 84, 417-427.
50. Hotamisligil GS (2003) Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 27, Suppl. 3, S53-S55. (Pubitemid 38019190)
51. White MF (2003) Insulin signalling in health and disease. Science 302, 1710-1711.
52. Pirola L, Johnston AM & Van Obberghen E (2004) Modulation of insulin action. Diabetologia 47, 170-184. (Pubitemid 38315353)
53. Bennet PA, Lindell K, Karlsson C, et al. (1998) Differential expression and regulation of leptin receptor isoforms in the rat brain: effects of fasting and oestrogen. Neuroendocrinology 67, 29-36. (Pubitemid 28039377)
54. López IP, Marti A, Milagro FI, et al. (2003) DNA microarray analysis of genes differentially expressed in diet-induced (cafeteria) obese rats. Obes Res 11, 188-194. (Pubitemid 41127385)
55. Wang M, Orci L, Ravazzola M, et al. (2005) Fat storage in adipocytes requires inactivation of leptin's paracrine activity: implications for treatment of human obesity. PNAS 102, 18011-18016. (Pubitemid 41798493)
56. Frederich RC, Löllmann B, Hamann A, et al. (1995) Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest 96, 1658-1663.
57. Luvizotto RA, Nascimento AF, S?́bio MT, et al. (2012) Experimental hyperthyroidism decreases gene expression and serum levels of adipokines in obesity. ScientificWorldJournal 2012, 780890.
58. Sierra-Honigmann MR, Nath AK, Murakami C, et al. (1998) Biological action of leptin as an angiogenic factor. Science 281, 1683-1686. (Pubitemid 28435586)
59. Lee SW, Park MC, Park YB, et al. (2007) Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis. Rheumatol Int 27, 537-540.
60. Targonska-Stepniak B, Majdan M & Dryglewska M (2008) Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity. Rheumatol Int 28, 585-591. (Pubitemid 351422621)
61. Gregor MF & Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29, 415-445.
62. Satapathy SK, Ochani M, Dancho M, et al. (2011) Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice. Mol Med 17, 599-606.
63. Steppan CM, Bailey ST, Bhat S, et al. (2001) The hormone resistin links obesity to diabetes. Nature 409, 307-312. (Pubitemid 32151228)
64. Ohmori R, Momiyama Y, Kato R, et al. (2005) Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J Am Coll Cardiol 46, 379-380. (Pubitemid 40966873)
65. Reilly MP, Lehrke M, Wolfe ML, et al. (2005) Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111, 932-939. (Pubitemid 40279897)
66. Zhang Z, Xing X, Hensley G, et al. (2010) Resistin induces expression of proinflammatory cytokines and chemokines in human articular chondrocytes via transcription and messenger RNA stabilization. Arthritis Rheum 62, 1993-2003.
67. Kuzmicki M, Telejko B, Szamatowicz J, et al. (2009) High resistin and interleukin-6 levels are associated with gestational diabetes mellitus. Gynecol Endocrinol 25, 258-263.